Akari Therapeutics Plc (AKTX)
Akari Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. Its lead product candidate, Nomacopan, is a second-generation complement inhibitor. The company was founded on October 7, 2004 and is headquartered in Boston, MA.
Address
22 BOSTON WHARF ROAD
BOSTON, MA 02210
Founded
2004
Number of Employees
-
Website
http://www.akaritx.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)